Penwest Announces That the Results of Its Annual Meeting Have Been Certified Jun 25, 2009
" About Penwest Pharmaceuticals Penwest is a drug development company focused on identifying and developing products that address unmet medical needs, primarily for rare disorders of the nervous system. Penwest is currently developing A0001, a coenzyme Q analog drug candidate for inherited mitochondrial respiratory chain diseases. Penwest is also applying its drug delivery technologies and drug formulation expertise to the formulation of product candidates under licensing collaborations with... (Primezone Releases)
Washington State Court Denies Dissidents' Request for Preliminary Injunction in Penwest Proxy Vote May 23, 2009
Press Release Source: Penwest Pharmaceuticals Co. ... May 22, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (NasdaqGM: - ) announced today that the Superior Court of the State of Washington for King County has denied the preliminary injunction requested by Tang Capital Management, L.P. and Perceptive Life Sciences Master Fund Ltd. in the Company's proxy vote ... About Penwest Pharmaceuticals. (Primezone Releases)
Drug investors lose patience Mar 10, 2009
One company so tarred, by one of its biggest investors, is Penwest Pharmaceuticals. "The company's history is an unfortunate progression of failed development programs," Perceptive Advisors, an investor in the company, wrote in November to Penwest's board. (International Herald Tribune -- Business)
Endo and Penwest Announce Settlement of Opana(R) ER Litigation Feb 21, 2009
Feb. 20 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ), and Penwest Pharmaceuticals (Nasdaq: ) announced today that the companies have settled litigation with Actavis South Atlantic LLC regarding the production and sale of generic formulations of Opana(R) ER (oxymorphone hydrochloride) Extended Release Tablets CII. Endo and Penwest have agreed to dismiss their suit with prejudice and Actavis has agreed to dismiss its counterclaims with prejudice. Under the terms of the settlement,... (PR Newswire)
